Lithuanian Prostate Diagnostics Implementation Guide
0.0.1 - ci-build
Lithuanian Prostate Diagnostics Implementation Guide
0.0.1 - ci-build
Lithuanian Prostate Diagnostics Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-prostate/ and changes regularly. See the Directory of published versions
| Draft nuo 2025-03-24 |
<ConceptMap xmlns="http://hl7.org/fhir">
<id
value="conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate"/>
<language value="lt"/>
<text>
<status value="generated"/>
<div xml:lang="lt" lang="lt"><hr/><p><b>Lithuanian</b></p><hr/><p class="res-header-id"><b>Generated Narrative: ConceptMap conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate</b></p><a name="lt-conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate"> </a><a name="lt-hcconceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Language: en</p></div><p>Mapping from (not specified) to (not specified)</p><br/><p><b>Group 1 </b>Mapping from <a href="CodeSystem-prostate-pathology-questionnaire-item.html">Prostate pathology ESPBI Questionnaire item (linkId)version: 0.0.1)</a> to <a href="CodeSystem-prostate-fhir-mapping-target.html">Prostate questionnaire → FHIR mapping target (illustrative)version: 0.0.1)</a></p><table class="grid"><tr><td><b>Source Code</b></td><td><b>Relationship</b></td><td><b>Target Code</b></td><td><b>Comment</b></td></tr><tr><td>bioptate-length-mm (Bioptate length (mm))</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to" title="related-to">is related to</a></td><td>specimen-dimension-or-measurement (Specimen / Observation specimen measurement (TumorMeasurementLtLab, gross))</td><td>Specimen dimension or Observation-observation-specimen-measurement-example (LT Lab).</td></tr><tr><td>specimen-quality (Quality of materials)</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to" title="related-to">is related to</a></td><td>specimen-adequacy-finding (Observation: specimen adequacy (LT Lab))</td><td>Observation-observation-specimen-adequacy-example (LT Lab); map answerCoding to SNOMED finding codes from national spec.</td></tr><tr><td>treatment-effect (Treatment effect on tumour)</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to" title="related-to">is related to</a></td><td>observation-tumor-treatment-effect (Observation: tumor treatment effect (TumorObservableLtLab))</td><td>TumorObservableLtLab or narrative in DiagnosticReport; map radiotherapy/hormone SNOMED from spreadsheet.</td></tr><tr><td>histological-type (Primary histological type)</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to" title="related-to">is related to</a></td><td>condition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O))</td><td>Condition.code / morphology; Condition-condition-prostate-cancer-example (LT Lab) for integrated staging.</td></tr><tr><td>histological-comment (Histological type comment)</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to" title="related-to">is related to</a></td><td>condition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O))</td><td>Condition.note or Observation.note; complements histological-type.</td></tr><tr><td>isup-grade-group</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to" title="related-to">is related to</a></td><td>observation-gleason-isup-prostate (GleasonIsupObservationLtProstate + ProstateIsupGradeGroupVS)</td><td>GleasonIsupObservationLtProstate + ValueSet prostate-isup-grade-group. Example: Observation-observation-prostate-gleason-gradegroup-example.</td></tr><tr><td>idc-status (Intraductal carcinoma (IDC))</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to" title="related-to">is related to</a></td><td>observation-tumor-microscopic-idc (TumorObservableLtLab / morphology for IDC)</td><td>TumorObservableLtLab / morphology Observation; national form has additional IDC sub-questions.</td></tr><tr><td>cribriform-status (Cribriform glands)</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to" title="related-to">is related to</a></td><td>observation-tumor-microscopic-cribriform (TumorObservableLtLab / morphology for cribriform)</td><td>TumorObservableLtLab or structured finding Observation.</td></tr><tr><td>pattern4-pct-band (Pattern 4 quantity (percent band))</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to" title="related-to">is related to</a></td><td>observation-pattern4-percent (Observation: Pattern 4 percent band (lab tumour measurement patterns))</td><td>TumorMeasurementLtLab or lab tumour Observation; dr-prostate has finer bands than this Questionnaire.</td></tr><tr><td>tumor-percent-in-biopsy (Tumour percentage in biopsy tissue)</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to" title="related-to">is related to</a></td><td>observation-tumor-burden-percent (Observation: tumour percentage in biopsy tissue)</td><td>Quantitative tumour assessment row in dr-prostate; map to Observation ratio or coded category.</td></tr><tr><td>periprostatic-fat-invasion</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to" title="related-to">is related to</a></td><td>observation-periprostatic-invasion (Observation: periprostatic fat / seminal vesicle invasion (LT Lab tumour findings))</td><td>NeoplasmInvasionLtProstate (imaging) vs microscopic finding in pathology Observation; use LT Lab tumour findings for biopsy.</td></tr><tr><td>perineural-invasion</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to" title="related-to">is related to</a></td><td>observation-perineural-invasion (Observation: perineural invasion finding (LT Lab tumour findings))</td><td>SNOMED 369731000 (present), 370051000 (absent), 385001000 (not identified), 396393005 (indeterminate); use LT Lab tumour findings.</td></tr><tr><td>lymphovascular-invasion (Lymphatic and/or vascular tumour invasion)</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to" title="related-to">is related to</a></td><td>observation-lymphovascular-invasion (Observation: lymphovascular invasion finding (LT Lab tumour findings))</td><td>SNOMED 385414009 Lymphatic (small vessel) tumor invasion finding; use LT Lab tumour findings for biopsy microscopic assessment.</td></tr></table></div>
</text>
<url
value="https://hl7.lt/fhir/prostate/ConceptMap/prostate-pathology-questionnaire-to-fhir"/>
<version value="0.1.0"/>
<name value="ProstatePathologyQuestionnaireToFhir"/>
<title value="Prostate pathology Questionnaire items to FHIR mapping"/>
<status value="draft"/>
<experimental value="true"/>
<date value="2025-03-24"/>
<publisher value="Lithuanian Medical Library"/>
<contact>
<name value="Lithuanian Medical Library"/>
<telecom>
<system value="url"/>
<value value="https://medicinosnk.lt"/>
</telecom>
<telecom>
<system value="email"/>
<value value="info@medicinosnk.lt"/>
</telecom>
</contact>
<description
value="Maps dr-prostate-aligned pathology Questionnaire linkIds to LT Lab and LT Prostate Gleason/ISUP patterns."/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="LT"/>
</coding>
</jurisdiction>
<group>
<source
value="https://tx.hl7.lt/fhir/CodeSystem/prostate-pathology-questionnaire-item|0.0.1"/>
<target
value="https://tx.hl7.lt/fhir/CodeSystem/prostate-fhir-mapping-target|0.0.1"/>
<element>
<code value="bioptate-length-mm"/>
<display value="Bioptate length (mm)"/>
<target>
<code value="specimen-dimension-or-measurement"/>
<relationship value="related-to"/>
<comment
value="Specimen dimension or Observation-observation-specimen-measurement-example (LT Lab)."/>
</target>
</element>
<element>
<code value="specimen-quality"/>
<display value="Quality of materials"/>
<target>
<code value="specimen-adequacy-finding"/>
<relationship value="related-to"/>
<comment
value="Observation-observation-specimen-adequacy-example (LT Lab); map answerCoding to SNOMED finding codes from national spec."/>
</target>
</element>
<element>
<code value="treatment-effect"/>
<display value="Treatment effect on tumour"/>
<target>
<code value="observation-tumor-treatment-effect"/>
<relationship value="related-to"/>
<comment
value="TumorObservableLtLab or narrative in DiagnosticReport; map radiotherapy/hormone SNOMED from spreadsheet."/>
</target>
</element>
<element>
<code value="histological-type"/>
<display value="Primary histological type"/>
<target>
<code value="condition-morphology-prostate"/>
<relationship value="related-to"/>
<comment
value="Condition.code / morphology; Condition-condition-prostate-cancer-example (LT Lab) for integrated staging."/>
</target>
</element>
<element>
<code value="histological-comment"/>
<display value="Histological type comment"/>
<target>
<code value="condition-morphology-prostate"/>
<relationship value="related-to"/>
<comment
value="Condition.note or Observation.note; complements histological-type."/>
</target>
</element>
<element>
<code value="isup-grade-group"/>
<display value="ISUP grade group"/>
<target>
<code value="observation-gleason-isup-prostate"/>
<relationship value="related-to"/>
<comment
value="GleasonIsupObservationLtProstate + ValueSet prostate-isup-grade-group. Example: Observation-observation-prostate-gleason-gradegroup-example."/>
</target>
</element>
<element>
<code value="idc-status"/>
<display value="Intraductal carcinoma (IDC)"/>
<target>
<code value="observation-tumor-microscopic-idc"/>
<relationship value="related-to"/>
<comment
value="TumorObservableLtLab / morphology Observation; national form has additional IDC sub-questions."/>
</target>
</element>
<element>
<code value="cribriform-status"/>
<display value="Cribriform glands"/>
<target>
<code value="observation-tumor-microscopic-cribriform"/>
<relationship value="related-to"/>
<comment
value="TumorObservableLtLab or structured finding Observation."/>
</target>
</element>
<element>
<code value="pattern4-pct-band"/>
<display value="Pattern 4 quantity (percent band)"/>
<target>
<code value="observation-pattern4-percent"/>
<relationship value="related-to"/>
<comment
value="TumorMeasurementLtLab or lab tumour Observation; dr-prostate has finer bands than this Questionnaire."/>
</target>
</element>
<element>
<code value="tumor-percent-in-biopsy"/>
<display value="Tumour percentage in biopsy tissue"/>
<target>
<code value="observation-tumor-burden-percent"/>
<relationship value="related-to"/>
<comment
value="Quantitative tumour assessment row in dr-prostate; map to Observation ratio or coded category."/>
</target>
</element>
<element>
<code value="periprostatic-fat-invasion"/>
<display value="Periprostatic fat invasion"/>
<target>
<code value="observation-periprostatic-invasion"/>
<relationship value="related-to"/>
<comment
value="NeoplasmInvasionLtProstate (imaging) vs microscopic finding in pathology Observation; use LT Lab tumour findings for biopsy."/>
</target>
</element>
<element>
<code value="perineural-invasion"/>
<display value="Perineural invasion"/>
<target>
<code value="observation-perineural-invasion"/>
<relationship value="related-to"/>
<comment
value="SNOMED 369731000 (present), 370051000 (absent), 385001000 (not identified), 396393005 (indeterminate); use LT Lab tumour findings."/>
</target>
</element>
<element>
<code value="lymphovascular-invasion"/>
<display value="Lymphatic and/or vascular tumour invasion"/>
<target>
<code value="observation-lymphovascular-invasion"/>
<relationship value="related-to"/>
<comment
value="SNOMED 385414009 Lymphatic (small vessel) tumor invasion finding; use LT Lab tumour findings for biopsy microscopic assessment."/>
</target>
</element>
</group>
</ConceptMap>